When encapsulated in silica nanoparticles, peppermint oil and cinnamaldehyde, which gives cinnamon its characteristic flavor, penetrate biofılms and potently kill drug-resistant pathogens within them, according to Vincent Rotello at the University of Massachusetts, Amherst, and his collaborators. These nanocapsules also promote fı-broblast growth, which helps wounds to heal, they say, leading them to call these flavor-loaded nanoparticles a "promising natural disinfectant and wound cleanser." Details appeared 17 June 2015 in ACS Nano (doi:10.1021 /acsnano.5b01696). Nanomaterials offer two advantages over other products when it comes to treating bacterial biofılms, according to Rotello. They breach otherwise impenetrable layers surrounding biofılms, and they can be engineered to kill bacteria once inside. "Nanomaterials are an ideal way to launch a sneak attack on bacteria in a way that bacteria aren't ready for," he says. Although these nanocapsules can be stored stably, the acidic environment within biofılms breaks down the silica shell, releasing the peppermint oil and cinnamaldehyde. are co-cultured with 3T3 fıbroblasts, cinnamaldehyde, in particular, enhances fı-broblast growth. "This was a surprise," Rotello says. It turns out that cinnamaldehyde promotes insulin-like growth factor-1 signaling, a potent stimulator of collagen biosynthesis in fıbroblasts, he adds, citing published fındings by other investigators. He and his collaborators are beginning to test whether these flavor ingredient-loaded nanocapsules will promote wound healing in animals.
Plans call for developing these nanocapsules for use as a topical disinfectant to treat chronic skin wounds, according to Rotello. Treating wounds with topical preparations, which typically have fewer side effects, is preferable to using systemic drugs for individuals with chronic wounds, he says-imagining the nanocapsules as becoming "a super-charged version of Bactine™ that works against biofılms"-referring to a popular, overthe-counter antiseptic that is widely used to treat minor skin wounds.
Perhaps these loaded nanocapsules also can be developed to treat challenging internal biofılm infections, such as those that form along knee and hip replacements, catheters, or other indwelling medical devices, according to Rotello and his colleagues. Toward that end, they are shrinking the size of the nanocapsules from 2 m to 200 nm to test whether such smaller versions, when injected into infected animals, will safely and effectively disrupt internal biofılms.
Having such an approach for treating infections in biofılms "without harming underlying cells and tissues is the holy grail of antibacterial therapies," says Y.S. Prakash at the Mayo Clinic College of Medicine in Rochester, Minn. Moreover, combining the nanocapsules with antibiotics or other therapeutics might make them even more specifıc while minimizing toxicities, he suggests. "I'm very enthusiastic about where this avenue of clinically important research is going."
Carol Potera is a freelance writer in Great Falls, Mont. 
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Another Set of Microbiota Studies Involving the Gut or Other Anatomic Sites
Here in brief are findings from several recent reports of efforts to understand how microorganisms in the gut or elsewhere in the body affect the host:
• Despite reports to the contrary, there is no significant association between body mass index (BMI) and the relative abundance of any bacterial species within the mammalian gut microbiome, based on a meta-analysis of multiple studies, according to 
